lapatinib has been researched along with cnf 2024 in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (cnf 2024) | Trials (cnf 2024) | Recent Studies (post-2010) (cnf 2024) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 28 | 0 | 23 |
Protein | Taxonomy | lapatinib (IC50) | cnf 2024 (IC50) |
---|---|---|---|
Heat shock protein HSP 90-alpha | Homo sapiens (human) | 0.0394 | |
Heat shock protein HSP 90-beta | Homo sapiens (human) | 0.0464 | |
Endoplasmin | Canis lupus familiaris (dog) | 0.124 | |
Heat shock protein 75 kDa, mitochondrial | Homo sapiens (human) | 0.3125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for lapatinib and cnf 2024
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |